BIOMAT Database Logo BIOMAT Database Logo

Posttransplant anti-HLA antibodies: risk factor for chronic rejection? 1995

M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
Néphrologie-Immunologie Clinique, CHU TOURS, France.

UI MeSH Term Description Entries
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016009 Chi-Square Distribution A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another. Chi-Square Test,Chi Square Distribution,Chi Square Test,Chi-Square Distributions,Chi-Square Tests,Distribution, Chi-Square,Distributions, Chi-Square,Test, Chi-Square,Tests, Chi-Square

Related Publications

M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
Anti-HLA antibodies detected in posttransplant renal allograft recipient sera correlate with chronic rejection.
January 1997, Transplantation proceedings,
M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
Posttransplant antidonor antibodies and chronic rejection in renal transplantation.
November 1999, Transplantation proceedings,
M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.
December 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection.
February 2005, Transplantation,
M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
August 2009, Transplantation,
M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
Evaluation of Anti- HLA Class I Antibodies in Chronic Rejection of Kidney Transplantation.
June 2004, Iranian journal of allergy, asthma, and immunology,
M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome.
December 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
[Post-renal transplantatation humoral acute rejection or anti-HLA antibodies-mediated acute rejection].
January 2006, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
Non anti-HLA antibodies and acute rejection: A critical viewpoint
April 2019, Nephrologie & therapeutique,
M Buchler, and A al Najjar, and A Guerraoui, and J F Valentin, and M D Boulanger, and R Sherobeen, and A Lataste, and H Nivet, and Y Lebranchu
Posttransplant antibody response and chronic rejection.
September 1997, Transplantation proceedings,
Copied contents to your clipboard!